1,329 calculators and references across 60 specialties, with formula confidence shown up front.
Explanation and Clinical Context This tool translates guidance from the twenty twenty five American College of Cardiology and American Heart Association guideline for acute coronary syndromes into a structured approach to repeat twelve lead electrocardiograms in patients with suspected or confirmed acute coronary syndrome. The guideline recommends acquisition and interpretation of an ECG within ten minutes of first m
Serial Troponin Trajectory Interpretation. Comprehensive Explanation and Clinical Context Serial measurement of high sensitivity cardiac troponin plays a pivotal role in the diagnosis of acute coronary syndrome. The 2025 AHA ACS guideline emphasizes rapid rule in and rule out assessment using baseline and 1 to 2 hour repeat hs troponin values combined with clinical history and ECG findings. Serial trajectory interpre
Explanation and Clinical Context This tool is designed for patients with acute coronary syndromes who have undergone percutaneous coronary intervention with contemporary drug eluting stents and are treated with dual antiplatelet therapy that combines aspirin and an oral P2Y12 inhibitor. The 2025 acute coronary syndromes guideline identifies a default strategy of about 12 months of dual antiplatelet therapy in patient
Single Antiplatelet Therapy Transition for High Bleeding Risk: Explanation and Clinical Context Transition from dual antiplatelet therapy to single antiplatelet therapy is supported in the management of high bleeding risk patients after percutaneous coronary intervention according to the AHA ACS Guideline 2025. For patients with elevated bleeding tendency a shorter DAPT duration is reasonable and may safely reduce he
Single Sample hs Troponin Evaluation ≥3 Hours Symptom: Explanation and Clinical Context High sensitivity cardiac troponin is the preferred biomarker for evaluating suspected acute coronary syndrome. AHA 2025 guideline states that hs Troponin allows earlier rule out or rule in of myocardial infarction. When evaluating a patient who presents at least three hours from symptom onset a single hs Troponin below the assay s
Explanation and Clinical Context This tool supports bedside decisions about how urgent reperfusion should be in patients with suspected ST segment elevation myocardial infarction and which reperfusion strategy is most appropriate in a given clinical setting. It uses simple inputs that mirror key elements of the 2025 guideline for acute coronary syndromes including the type of hospital time from symptom onset to first
Stress Test versus Coronary Computed Tomography Before Discharge Pathway Tool Explanation and Clinical Context In contemporary management of acute coronary syndromes the two thousand twenty five guideline from the American College of Cardiology and the American Heart Association notes that selected patients can safely undergo either noninvasive stress testing or coronary computed tomography angiography before hospita
About SYNTAX II Score: The SYNTAX II Score combines anatomical and clinical variables to estimate 4-year mortality and guide revascularization strategy between PCI and CABG in patients with complex coronary artery disease. It improves upon the original SYNTAX I Score by incorporating key clinical parameters including age, sex, LVEF, renal function, COPD, PAD, and clinical presentation. Clinical Interpretation: A lowe
SYNTAX Score: Explanation and Clinical Context The SYNTAX Score is an angiographic tool to quantify the anatomical complexity of coronary artery disease by scoring each lesion with diameter stenosis of at least 50 percent in vessels of at least 1.5 millimeters. Each lesion is assigned a numeric value that reflects the myocardial territory at risk by a segment weight. The segment weight is multiplied by an occlusion m